← FDA Drug Approvals (Drugs@FDA)

RENVELA

NDA · New Drug Application · Sponsor: GENZYME · Approved 2009-08-12

Drug application

FDA Application #

NDA022318

Application type

New Drug Application

Brand name

RENVELA

Generic name

SEVELAMER CARBONATE

Active ingredients

SEVELAMER CARBONATE

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

GENZYME

Manufacturer

Sanofi-Aventis U.S. LLC

First approval

2009-08-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown